Thursday, October 16, 2025

5:30 PM-8:30 PM ET

Acute Leukemia & Myeloid Malignancies CME/CE Rounds
Philadelphia Marriott Downtown
Salons H-L
1201 Market Street
Guest entrance: 1200 Filbert Street
Philadelphia, PA 19107
 
*Blood Cancer United will cover valet parking at the Marriott for practicing healthcare professionals only, upon submission of your completed evaluation and feedback form.
 
*Only one (1) person per medical technology/pharmaceutical company may register and attend the Rounds. A corporate email address is required.
 
Pre-registration is required. 

Agenda

5:30 PM – Dinner and Networking
6:30 PM – Welcome, Program Overview, and Updates in Clinical Trials
Catherine Lai
6:40 PM – Overview of Blood Cancer United Resources
Amanda O'Neill
6:45 PM – Case Presentation and Panel Discussion on How I Treat Newly Diagnosed AML with Azacitadine + Venetoclax
Michael A. Brister; Gina Keiffer; Catherine Lai; Amogh Pathak; Keith Pratz; and Alexander Vartanov
7:30 PM – Case Presentation and Discussion on Reducing Phlebotomy Burden in Patients with PV
Lindsay R. Wilde and Pavan J. Patel
7:55 PM – Case Presentation and Discussion on Referring Older Adults with MDS/AML for BMT: Who and When
Alexander Vartanov and Aliya Rashid
8:20 PM – Discussion and wrap up
All Faculty
8:30 PM – Conclusion
Catherine Lai

Description

Interactive continuing medical education activity for healthcare professionals in Philadelphia, New Jersey, Delaware, and surrounding areas to discuss acute leukemia and myeloid malignancies updates and challenges in treatment.

Target Audience

This activity is intended for hematologists-oncologists, medical oncologists, physician associates, nurse practitioners, nurses and pharmacists involved in the care of patients with acute leukemia and myeloid malignancies. 

Learning Objectives

At the conclusion of this activity, participants will be better able to:
  • Explain the most recent data on novel treatment options in acute leukemias and myeloid malignancies
  • Discuss drug interactions with novel therapies and how to manage
  • Explain diagnostic and prognostic testing and challenges, relapse prevention and detection of measurable residual disease
  • Explain disparities and challenges in the diagnosis and treatment of acute leukemias and myeloid malignancies
  • Identify resources for patient education and support

Advisory Group

Catherine Lai, MD, MPH (Chair)
Hospital of the University of Pennsylvania
Philadelphia, PA
 
Katie Allen, CRNP
Hospital of the University of Pennsylvania
Philadelphia, PA
 
Michael A. Brister, MD
Cooper University Health Care 
Camden, NJ
 
Alison Carulli, PharmD, BCOP
Hospital of the University of Pennsylvania
Philadelphia, PA
 
Margie Kasner, MD, MSCE
Sidney Kimmel Comprehensive Cancer Center
Thomas Jefferson University
Philadelphia, PA
 
Grace Shyu, PA-C
Hospital of the University of Pennsylvania
Philadelphia, PA
 
Michael Styler, MD
Fox Chase Cancer Center
Temple University
Philadelphia, PA

Faculty

Catherine Lai, MD, MPH (Chair)
Hospital of the University of Pennsylvania
Philadelphia, PA
 

Michael A. Brister, MD
Cooper University Health Care 
Camden, NJ

Gina Keiffer, MD
Sidney Kimmel Cancer Comprehensive Center
Thomas Jefferson University
Philadelphia, PA
 

Amanda O’Neill, LMSW
Blood Cancer United
Washington, DC

Amogh Pathak, MD
MD Anderson Cancer Center at Cooper
Camden, NJ

Pavan J. Patel, MD
Thomas Jefferson University Hospital
Philadelphia, PA

Keith Pratz, MD
Hospital of the University of Pennsylvania
Philadelphia, PA

Aliya Rashid, DO, MPH
Fox Chase Cancer Center
Temple University 
Philadelphia, PA

Alexander Vartanov, MD
Fox Chase Cancer Center
Temple University
Philadelphia, PA

Lindsay R. Wilde, MD
Sidney Kimmel Comprehensive Cancer Center
Thomas Jefferson University Hospital
Philadelphia, PA

 
 
This activity is provided by Blood Cancer United and Medical Learning Institute Inc, in collaboration with the Association of Cancer Care Centers™ (ACCC).
 
 
 

Blood Cancer United thanks Autolus Therapeutics, Geron Corporation, and Novartis Pharmaceuticals Corporation for their financial support.

 

For questions, concerns, or assistance for people with disabilities or grievances, please contact us at: profeducation@LLS.org.

 

Follow Blood Cancer United